Celgene Corporation has announced it has received a Paragraph IV Notice Letter advising that Actavis LLC submitted an Abbreviated New...
Foresee Pharmaceuticals has announced the top-line result of FP 001 (leuprolide mesylate injectable suspension) 50mg phase III clinical trial, an...